# OnCo record bleomycin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bleomycin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bleomycin" ;
  schema:name "Bleomycin"@en ;
  schema:description "Bleomycin is the 'B' in BEP for testicular cancer and ABVD for Hodgkin lymphoma; its unique danger is scarring of the lungs, so lung function is monitored and it is often dropped when safe."@en ;
  schema:url <https://onco.cc/drugs/bleomycin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bleomycin> ;
  owl:sameAs <http://www.wikidata.org/entity/Q415571> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bleomycin> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "generic", "who-essential" ;
  onco:modality "Glycopeptide antibiotic (DNA-cleaving)" ;
  schema:alternateName "Blenoxane" ;
  onco:approval "US 1973: Squamous cell carcinomas, Hodgkin and non-Hodgkin lymphoma, testicular carcinoma, malignant pleural effusion" ;
  onco:cancers <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/seminoma/>, <https://onco.cc/cancers/non-seminoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/electrochemotherapy/> ;
  onco:terms <https://onco.cc/terms/ild/> .